Jeffrey Brewer

About

As an entrepreneurial business leader with a proven track record in technology and healthcare innovation, I co-founded Bigfoot Biomedical and spearheaded the development of a category-defining diabetes care solution for people with insulin-requiring diabetes. My expertise lies in driving industry-wide progress by strategically applying technology and innovative business models, navigating regulatory, reimbursement, and market access challenges, and guiding complex healthcare ecosystems to prioritize patient-centered solutions. I led significant business-building efforts, including Abbott’s acquisition of Bigfoot Biomedical in 2023. Known for developing and commercializing technology IP, I have scaled operations and cultivated mission-driven teams to forge new pathways in healthcare. My career is marked by a commitment to innovation and excellence, consistently pushing the boundaries of what is possible at the intersection of technology and healthcare. Key strengths include the following: Innovation Spearheaded the development and delivery of Bigfoot Unity Diabetes Management System, the first FDA-cleared system translating continuous glucose monitoring (CGM) data into insulin dose

Experience

Education